Abstract
Resistance to thyroid hormone (RTH) is a rare autosomal dominant disease characterized by an alteration of thyroid hormone negative feedback, usually as a consequence of a mutation in the thyroid hormone receptor-b gene (THRβ). It is characterized by high variability of clinical manifestations, ranging from isolated abnormal thyroid function tests without symptoms to severe and impaired clinical conditions. Here we report the case of a woman who was diagnosed with RTHβ when she was 35 years old and was treated with 3,5,3-triiodiothyroacetic acid (TRIAC) because of the onset of clinical symptoms of hyperthyroidism. This therapy has been effective in controlling thyrotoxicosis for 5 years. After this time the patient developed an autoimmune hyperthyroidism, with TSH receptor autoantibodies appearance, which caused a loss of efficacy of the drug in controlling the disease. The development of different pathophysiological mechanisms of thyrotoxicosis, as in this case, could be the reason for both variability of disease manifestations and of loss of response to drug therapy.
Similar content being viewed by others
References
N. Messier, L. Laflamme, G. Hamann, M.F. Langlois, In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy. Mol. Cell Endocrinol. 174, 59–69 (2001). https://doi.org/10.1016/S0303-7207(00)00446-9
S. Refetoff, R.E. Weiss, S.J. Usala, The syndromes of resistance to thyroid hormone. Endocr. Rev. 14, 348–399 (1993). https://doi.org/10.1210/EDRV-14-3-348
W.E. Visser, Therapeutic applications of thyroid hormone analogues. Ann. Endocrinol. 82, 170–172 (2021). https://doi.org/10.1016/j.ando.2020.03.004
P. Beck-Peccoz, L. Persani, S. Mantovani, D. Cortelazzi, C. Asteria, Thyrotropin-secreting pituitary adenomas. Metabolism 45, 75–78 (1996). https://doi.org/10.1016/S0026-0495(96)90089-X
B. Yao, C. Yang, C. Pan, Y. Li, Thyroid hormone resistance: Mechanisms and therapeutic development. Mol. Cell. Endocrinol. 553, 111679 (2022). https://doi.org/10.1016/j.mce.2022.111679
M. Adams, C. Matthews, T.N. Collingwood, Y. Tone, P. Beck-Peccoz, K.K. Chatterjee, Genetic Analysis of 29 Kindreds with Generalized and Pituitary Resistance to Thyroid Hormone: Identification of Thirteen Novel Mutations in the Thyroid Hormone Receptor β Gene. J. Clin. Investig. 94, 506–515 (1994). https://doi.org/10.1172/jci117362
R. Zucchi, Thyroid Hormone Analogues: An Update. Thyroid 30, 1099–1105 (2020). https://doi.org/10.1089/THY.2020.0071
H. Sato, Clinical features of primary hyperthyroidism caused by Graves’ disease admixed with resistance to thyroid hormone (P453T). Endocr. J. 57, 687–692 (2010). https://doi.org/10.1507/endocrj.K10E-066
F. Rosignolo, V. Maggisano, M. Sponziello, M. Celano, C.R.T. Di Gioia, M. D’Agostino, L. Giacomelli, A. Verrienti, M. Dima, V. Pecce, C. Durante, Reduced expression of THRβ in papillary thyroid carcinomas: Relationship with BRAF mutation, aggressiveness and miR expression. J. Endocrinological Investig. 38, (2015). https://doi.org/10.1007/s40618-015-0309-4
R. Parrilla, A.J. Mixson, J.A. McPherson, J.H. McClaskey, B.D. Weintraub, Characterization of seven novel mutations of the c-erbAβ gene in unrelated kindreds with generalized thyroid hormone resistance: Evidence for two “hot spot” regions of the ligand binding domain. J. Clin. Investig. 88, 2123–2130 (1991). https://doi.org/10.1172/JCI115542
S. Groeneweg, R.P. Peeters, T.J. Visser, W.E. Visser, Triiodothyroacetic acid in health and disease. J. Endocrinol. 234, R99–R121 (2017). https://doi.org/10.1530/JOE-17-0113
T. Takeda, S. Suzuki, R.T. Liu, L.J. DeGroot, Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 80, 2033–2040 (1995). https://doi.org/10.1210/jcem.80.7.7608251
H. Sun, S. Xu, S. Xie, W. Cao, G. Chen, H. Di, R. Zheng, X. Li, X. Mao, C. Liu, Graves’ disease coexisting with resistance to thyroid hormone: a rare case. Clin. Case Rep. 6, 337–341 (2018). https://doi.org/10.1002/ccr3.1344
C.C. Larsen, A. Dumitrescu, L.M. Guerra-Argüero, C. Gállego-Suárez, A. Vazquez-Mellado, M. Vinogradova, R. Fletterick, S. Refetoff, R.E. Weiss, Incidental identification of a thyroid hormone receptor beta (THRB) gene variant in a family with autoimmune. Thyroid. Dis. Thyroid. 23, 1638–1643 (2013). https://doi.org/10.1089/THY.2013.0174
T. Shiwa, K. Oki, T. Awaya, S. Nakanishi, K. Yamane, Resistance to thyroid hormone accompanied by Graves’ disease. Intern. Med. 50, 1977–1980 (2011). https://doi.org/10.2169/internalmedicine.50.4904
Author information
Authors and Affiliations
Contributions
A.C. and A.V. wrote the main manuscript text. D.S.C. prepared figures. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Carbone, A., Verrienti, A., Cito, D.S. et al. Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance. Endocrine (2024). https://doi.org/10.1007/s12020-024-03795-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12020-024-03795-3